Prevalence of anti-hepatitis C antibodies in a rural community without high mortality from liver disease in niigata prefecture

Journal of Epidemiology

Volumn 8, Issue 4, 1998, Pages 250-255

  Kayaba, Kazunori ^a,c   Igarashi, Masahiro ^a   Okamoto, Hiroaki ^b   Tsuda, Fumio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Shinagawa ku   (Japan)

^c Yamato Health Examination Center   (Japan)

Author keywords

Anti hepatitis c virus antibodies; Hepatitis c virus; Population based study

Indexed keywords

ACUPUNCTURE; ARTICLE; FEMALE; HEALTH; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; JAPAN; LIVER DISEASE; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; RISK FACTOR; STATISTICS;

ACUPUNCTURE THERAPY; FEMALE; HEALTH SURVEYS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; JAPAN; LIVER DISEASES; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL HEALTH; STATISTICS;

EID: 37849186985     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: 10.2188/jea.8.250     Document Type: Article

References (22)

1. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med, 1993;328:1797-1801.
2. Health and Welfare Statistics Association. National public health, its trend. Kosei-no-Shihyo, 1996;43:47-80 (in Japanese).
3. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med, 1996; 125:658-668.
4. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer, 1997;79:1494-1500.
5. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redecker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science, 1989:244:362-364.
6. Yoshihara N, Oota Y, Okabe N, Akiba T. Epidemiology of hepatitis C virus infection -Japan, China, Tonga, Fiji, Philipine-. In;. Tanaka K and Obara M, eds. Hepatitis C, HCV detection and interferon therapy. Medical View, 1994:108-112 (in Japanese).
7. Tanaka J, Moriya T, Sasaki F, Yoshizawa H, Nagakami H, Irie A, Mizui M. Prevalence of anti C100-3 and HBsAg in blood donors. Nihon Koshu Eisei Zasshi, 1993;40:540-546 (in Japanese).
8. Ishibashi M, Shinzawa H, Kuboki M, Tsuchida H, and Takahashi T. Prevalence of inhabitants with anti-hepatitis C virus antibody in an area following an acute hepatitis C epidemic : age- and area-related features. J Epidemiol, 1996;6:l-8.
9. Hidaka Y, Hiramatsu Y, Tsuda F. High prevalence of HCV infection in a town where high mortality from liver disease is observed. Nihon Koshu Eisei Zasshi, 1996;43:9-15 (in Japanese).
10. Watanabe Y, Machida K, Sato A, Ota S, Kiyosawa K. Survey for hepatitis in an isolated endemic area. Nihon Koshu Eisei Zasshi, 1996; 43: 989-996 (in Japanese).
11. Koyama T, Tsuda F, Ishikawa K, Onishi H, Tazawa M, Yoshizawa H, Sato S, Okamoto H. Antibodies to hepatitis C virus and elevated transaminase levels in a town of hyperendemicity in I wate, Japan. J Gastroenterol Hepatol, 1997;12:67-72.
12. Niigataken Seijinnbyo Yobou Kyoukai. Standardized Mortality Ratio in Niigata prefecture 1989-1993. 1996, 47-48 (in Japanese).
13. Okamoto H, Munekata E, Tsuda F, Takahashi K, Yotsumoto S, Tanaka T, Tachibana K, Akahane Y, Sugai Y, Miyakawa Y, Mayumi M. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide. Japan J Exp Med, 1990;60:223-233.
14. Nagayama R, Miyake K, Tsuda F, Okamoto H. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol, 1994;42:311-317.
15. Morris JA, Gardner MJ. Calculating confidence intervals for relative risks, odds ratios, and standardised ratios and rates.In; Gardner MJ and Altman DG, eds. Statistics with confidence - Confidence intervals and statistical guidelines, British Medical Journal, 1989:50-63.
16. Nakashima K, Kashiwagi S, Hayashi J, Urabe K, Minami K, Maeda Y. Prevalence of hepatitis C virus infection among female prostitutes in Fukuoka, Japan. J Gastroenterol, 1996;31:664-668.
17. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care, 1996;19:998-1000.
18. Yano M. Epidemiology of hepatitis C virus infection in Japan. Nippon Rinsho, 1995;53 supplement:346-350 (in Japanese).
19. Tanaka J, Sasaki F, Nagakami H, Mizui M, Katayama K, Moriya H, Yoshizawa K. Estimating numbers of HBV carrier and HCV carrier in Hiroshima and Japan using data from blood donors. Nihon Koshu Eisei Zasshi 1997;44:788-796 (in Japanese).
20. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology, 1990;12(4pt l):671-675.
21. Ministry of Health and Welfare. Prevention of hepatitis B infection in health care. Recommendation from department of health policy No 37,1987 (in Japanese).
22. Safety guideline committee for aqupunctute and moxibustion. Infection prevention for an acupuncturist and a moxa therapist. In; Kobayashi H, ed. The guideline for preventing infectious disease in acupuncture and moxibustion. Meiji-Shinnkyu Collage, Kyoto, 1992:49-62 (in Japanese).